• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Computationally-predicted CB1 cannabinoid receptor mutants show distinct patterns of salt-bridges that correlate with their level of constitutive activity reflected in G protein coupling levels, thermal stability, and ligand binding.计算机预测的 CB1 大麻素受体突变体显示出不同的盐桥模式,这些模式与它们在 G 蛋白偶联水平、热稳定性和配体结合方面反映的组成型活性水平相关。
Proteins. 2013 Aug;81(8):1304-17. doi: 10.1002/prot.24264. Epub 2013 Jun 14.
2
Molecular basis for dramatic changes in cannabinoid CB1 G protein-coupled receptor activation upon single and double point mutations.单、双点突变导致大麻素 CB1 G 蛋白偶联受体激活的显著变化的分子基础。
Protein Sci. 2013 Jan;22(1):101-13. doi: 10.1002/pro.2192.
3
Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation.变构调节剂 ORG27569 诱导 CB1 大麻素受体高亲和力激动剂结合状态、受体内化和 Gi 蛋白非依赖性 ERK1/2 激酶激活。
J Biol Chem. 2012 Apr 6;287(15):12070-82. doi: 10.1074/jbc.M111.316463. Epub 2012 Feb 16.
4
A cannabinoid receptor 1 mutation proximal to the DRY motif results in constitutive activity and reveals intramolecular interactions involved in receptor activation.DRY 基序附近的大麻素受体 1 突变导致组成型活性,并揭示了受体激活过程中涉及的分子内相互作用。
Brain Res. 2006 Sep 7;1108(1):1-11. doi: 10.1016/j.brainres.2006.05.042. Epub 2006 Jul 31.
5
Structural dynamics and energetics underlying allosteric inactivation of the cannabinoid receptor CB1.大麻素受体CB1变构失活背后的结构动力学与能量学
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8469-74. doi: 10.1073/pnas.1500895112. Epub 2015 Jun 22.
6
The effects of charge-neutralizing mutation D6.30N on the functions of CB1 and CB2 cannabinoid receptors.电荷中和突变D6.30N对CB1和CB2大麻素受体功能的影响。
FEBS Lett. 2006 Oct 2;580(22):5392-8. doi: 10.1016/j.febslet.2006.09.001. Epub 2006 Sep 12.
7
Structural mimicry in class A G protein-coupled receptor rotamer toggle switches: the importance of the F3.36(201)/W6.48(357) interaction in cannabinoid CB1 receptor activation.A类G蛋白偶联受体旋转异构体切换开关中的结构模拟:大麻素CB1受体激活中F3.36(201)/W6.48(357)相互作用的重要性。
J Biol Chem. 2004 Nov 12;279(46):48024-37. doi: 10.1074/jbc.M406648200. Epub 2004 Aug 23.
8
Mutations of CB1 T210 produce active and inactive receptor forms: correlations with ligand affinity, receptor stability, and cellular localization.CB1 T210的突变产生活性和非活性受体形式:与配体亲和力、受体稳定性和细胞定位的相关性。
Biochemistry. 2006 May 2;45(17):5606-17. doi: 10.1021/bi060067k.
9
Molecular basis of cannabinoid CB1 receptor coupling to the G protein heterotrimer Gαiβγ: identification of key CB1 contacts with the C-terminal helix α5 of Gαi.大麻素 CB1 受体与 G 蛋白异三聚体 Gαiβγ偶联的分子基础:鉴定 CB1 与 Gαi 的 C 末端螺旋 α5 的关键接触部位。
J Biol Chem. 2013 Nov 8;288(45):32449-32465. doi: 10.1074/jbc.M113.489153. Epub 2013 Oct 3.
10
Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα protein inhibitor.利莫那班,一种有效的 CB1 cannabinoid 受体拮抗剂,是一种 Gα 蛋白抑制剂。
Neuropharmacology. 2018 May 1;133:107-120. doi: 10.1016/j.neuropharm.2018.01.024.

引用本文的文献

1
Differential Behavior of Conformational Dynamics in Active and Inactive States of Cannabinoid Receptor 1.大麻素受体 1 活性状态和非活性状态构象动力学的差异行为。
J Phys Chem B. 2024 Sep 5;128(35):8437-8447. doi: 10.1021/acs.jpcb.4c02828. Epub 2024 Aug 22.
2
Structural and dynamic insights into the activation of the μ-opioid receptor by an allosteric modulator.别构调节剂激活 μ 阿片受体的结构和动力学研究。
Nat Commun. 2024 May 13;15(1):3544. doi: 10.1038/s41467-024-47792-6.
3
Predicted structure of fully activated human bitter taste receptor TAS2R4 complexed with G protein and agonists.与G蛋白和激动剂复合的完全激活的人类苦味受体TAS2R4的预测结构。
QRB Discov. 2021 Apr 8;2:e3. doi: 10.1017/qrd.2021.1. eCollection 2021.
4
Predicted structure and cell signaling of TAS2R14 reveal receptor hyper-flexibility for detecting diverse bitter tastes.TAS2R14的预测结构和细胞信号揭示了其检测多种苦味的受体高度灵活性。
iScience. 2023 Mar 16;26(4):106422. doi: 10.1016/j.isci.2023.106422. eCollection 2023 Apr 21.
5
Activation mechanism of the μ-opioid receptor by an allosteric modulator.变构调节剂对 μ 阿片受体的激活机制。
Proc Natl Acad Sci U S A. 2022 Apr 19;119(16):e2121918119. doi: 10.1073/pnas.2121918119. Epub 2022 Apr 11.
6
Development of enhanced conformational sampling methods to probe the activation landscape of GPCRs.开发增强构象采样方法以探测 GPCR 激活景观。
Adv Protein Chem Struct Biol. 2022;128:325-359. doi: 10.1016/bs.apcsb.2021.11.001. Epub 2021 Dec 20.
7
Understanding the role of the CB1 toggle switch in interaction networks using molecular dynamics simulation.利用分子动力学模拟理解 CB1 拨动开关在相互作用网络中的作用。
Sci Rep. 2021 Nov 16;11(1):22369. doi: 10.1038/s41598-021-01767-5.
8
Structures and Agonist Binding Sites of Bitter Taste Receptor TAS2R5 Complexed with Gi Protein and Validated against Experiment.苦味受体 TAS2R5 与 Gi 蛋白复合物的结构和激动剂结合位点,并经过实验验证。
J Phys Chem Lett. 2021 Sep 30;12(38):9293-9300. doi: 10.1021/acs.jpclett.1c02162. Epub 2021 Sep 20.
9
Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids.大麻素受体 1 变构调节剂的合理设计:Org27569 和 PSNCBAM-1 的杂合体。
Bioorg Med Chem. 2021 Jul 1;41:116215. doi: 10.1016/j.bmc.2021.116215. Epub 2021 May 12.
10
Probing thermostability of detergent-solubilized CB receptor by parallel G protein-activation and ligand-binding assays.通过平行的 G 蛋白激活和配体结合测定法探测去污剂增溶 CB 受体的热稳定性。
J Biol Chem. 2020 Jan 3;295(1):181-190. doi: 10.1074/jbc.RA119.010696. Epub 2019 Nov 27.

本文引用的文献

1
Flat-Bottom Strategy for Improved Accuracy in Protein Side-Chain Placements.用于提高蛋白质侧链放置准确性的平底策略。
J Chem Theory Comput. 2008 Dec 9;4(12):2160-9. doi: 10.1021/ct800196k.
2
Molecular basis for dramatic changes in cannabinoid CB1 G protein-coupled receptor activation upon single and double point mutations.单、双点突变导致大麻素 CB1 G 蛋白偶联受体激活的显著变化的分子基础。
Protein Sci. 2013 Jan;22(1):101-13. doi: 10.1002/pro.2192.
3
Structure prediction of G protein-coupled receptors and their ensemble of functionally important conformations.G蛋白偶联受体的结构预测及其功能重要构象集合
Methods Mol Biol. 2012;914:237-54. doi: 10.1007/978-1-62703-023-6_14.
4
Ligand functional selectivity and quantitative pharmacology at G protein-coupled receptors.配体功能选择性和 G 蛋白偶联受体的定量药理学。
Expert Opin Drug Discov. 2011 Aug;6(8):811-25. doi: 10.1517/17460441.2011.586691. Epub 2011 May 24.
5
Crystal structure of a lipid G protein-coupled receptor.脂质 G 蛋白偶联受体的晶体结构。
Science. 2012 Feb 17;335(6070):851-5. doi: 10.1126/science.1215904.
6
Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation.变构调节剂 ORG27569 诱导 CB1 大麻素受体高亲和力激动剂结合状态、受体内化和 Gi 蛋白非依赖性 ERK1/2 激酶激活。
J Biol Chem. 2012 Apr 6;287(15):12070-82. doi: 10.1074/jbc.M111.316463. Epub 2012 Feb 16.
7
Bihelix: Towards de novo structure prediction of an ensemble of G-protein coupled receptor conformations.双螺旋:迈向G蛋白偶联受体构象集合的从头结构预测。
Proteins. 2012 Feb;80(2):505-18. doi: 10.1002/prot.23216. Epub 2011 Dec 15.
8
Activation mechanism of the β2-adrenergic receptor.β2-肾上腺素受体的激活机制。
Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18684-9. doi: 10.1073/pnas.1110499108. Epub 2011 Oct 26.
9
Structural mechanisms of constitutive activation in the C5a receptors with mutations in the extracellular loops: molecular modeling study.C5a 受体胞外环突变导致组成性激活的结构机制:分子建模研究。
Proteins. 2012 Jan;80(1):71-80. doi: 10.1002/prot.23162. Epub 2011 Sep 30.
10
Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine.腺苷 A(2A)受体与 ZM241385、黄嘌呤衍生物 XAC 和咖啡因复合物的结构。
Structure. 2011 Sep 7;19(9):1283-93. doi: 10.1016/j.str.2011.06.014.

计算机预测的 CB1 大麻素受体突变体显示出不同的盐桥模式,这些模式与它们在 G 蛋白偶联水平、热稳定性和配体结合方面反映的组成型活性水平相关。

Computationally-predicted CB1 cannabinoid receptor mutants show distinct patterns of salt-bridges that correlate with their level of constitutive activity reflected in G protein coupling levels, thermal stability, and ligand binding.

机构信息

Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut 06269-3092, USA.

出版信息

Proteins. 2013 Aug;81(8):1304-17. doi: 10.1002/prot.24264. Epub 2013 Jun 14.

DOI:10.1002/prot.24264
PMID:23408552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4872635/
Abstract

The cannabinoid receptor 1 (CB1), a member of the class A G-protein-coupled receptor (GPCR) family, possesses an observable level of constitutive activity. Its activation mechanism, however, has yet to be elucidated. Previously we discovered dramatic changes in CB1 activity due to single mutations; T3.46A, which made the receptor inactive, and T3.46I and L3.43A, which made it essentially fully constitutively active. Our subsequent prediction of the structures of these mutant receptors indicated that these changes in activity are explained in terms of the pattern of salt-bridges in the receptor region involving transmembrane domains 2, 3, 5, and 6. Here we identified key salt-bridges, R2.37 + D6.30 and D2.63 + K3.28, critical for CB1 inactive and active states, respectively, and generated new mutant receptors that we predicted would change CB1 activity by either precluding or promoting these interactions. We find that breaking the R2.37 + D6.30 salt-bridge resulted in substantial increase in G-protein coupling activity and reduced thermal stability relative to the wild-type reflecting the changes in constitutive activity from inactive to active. In contrast, breaking the D2.63 + K3.28 salt-bridge produced the opposite profile suggesting this interaction is critical for the receptor activation. Thus, we demonstrate an excellent correlation with the predicted pattern of key salt-bridges and experimental levels of activity and conformational flexibility. These results are also consistent with the extended ternary complex model with respect to shifts in agonist and inverse agonist affinity and provide a powerful framework for understanding the molecular basis for the multiple stages of CB1 activation and that of other GPCRs in general.

摘要

大麻素受体 1(CB1)是 A 类 G 蛋白偶联受体(GPCR)家族的成员,具有可观察到的固有活性。然而,其激活机制尚未阐明。以前,我们发现由于单一突变,CB1 活性会发生剧烈变化;T3.46A 使受体失活,而 T3.46I 和 L3.43A 使它基本完全固有激活。我们随后对这些突变受体的结构进行了预测,表明这些活性变化可以用涉及跨膜域 2、3、5 和 6 的受体区域中的盐桥模式来解释。在这里,我们确定了关键的盐桥,R2.37 + D6.30 和 D2.63 + K3.28,分别对 CB1 的非活性和活性状态至关重要,并生成了我们预测会改变 CB1 活性的新突变受体,要么排除要么促进这些相互作用。我们发现,打破 R2.37 + D6.30 盐桥会导致 G 蛋白偶联活性的大幅增加,并降低与野生型相比的热稳定性,反映了从非活性到活性的固有活性变化。相比之下,打破 D2.63 + K3.28 盐桥产生了相反的结果,表明这种相互作用对于受体的激活至关重要。因此,我们证明了与预测的关键盐桥模式和实验活性和构象灵活性水平之间的极好相关性。这些结果也与扩展的三元复合物模型一致,涉及激动剂和反向激动剂亲和力的变化,并为理解 CB1 激活的多个阶段以及其他 GPCR 一般的分子基础提供了一个强大的框架。